BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 19956657)

  • 1. The specificity of the FOXL2 c.402C>G somatic mutation: a survey of solid tumors.
    Schrader KA; Gorbatcheva B; Senz J; Heravi-Moussavi A; Melnyk N; Salamanca C; Maines-Bandiera S; Cooke SL; Leung P; Brenton JD; Gilks CB; Monahan J; Huntsman DG
    PLoS One; 2009 Nov; 4(11):e7988. PubMed ID: 19956657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional exploration of the adult ovarian granulosa cell tumor-associated somatic FOXL2 mutation p.Cys134Trp (c.402C>G).
    Benayoun BA; Caburet S; Dipietromaria A; Georges A; D'Haene B; Pandaranayaka PJ; L'Hôte D; Todeschini AL; Krishnaswamy S; Fellous M; De Baere E; Veitia RA
    PLoS One; 2010 Jan; 5(1):e8789. PubMed ID: 20098707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The FOXL2 mutation (c.402C>G) in adult-type ovarian granulosa cell tumors of three Japanese patients: clinical report and review of the literature.
    Takahashi A; Kimura F; Yamanaka A; Takebayashi A; Kita N; Takahashi K; Murakami T
    Tohoku J Exp Med; 2013 Dec; 231(4):243-50. PubMed ID: 24257635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of wild-type but not C134W mutant FOXL2 enhances GnRH-induced cell apoptosis by increasing GnRH receptor expression in human granulosa cell tumors.
    Cheng JC; Klausen C; Leung PC
    PLoS One; 2013; 8(1):e55099. PubMed ID: 23372819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of FOXL2 C134W Mutation Status by a Novel BaseScope In Situ Hybridization Assay is Highly Sensitive and Specific for Adult Granulosa Cell Tumors.
    Hammer PM; Wang A; Beard C; Zdravkovic S; Tenney T; Liang B; Das I; Bremer R; Wang LC; McCluggage WG; Stewart CJR; Howitt BE
    Mod Pathol; 2023 Nov; 36(11):100318. PubMed ID: 37634867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of a FOXL2 mutation (402C→G) in the blood of adult-type granulosa cell tumor patients possessing the FOXL2 mutation.
    Lee S; Kim TH; Won M; Ko JJ; Rho J; Lee K; Bae J
    Int J Gynecol Cancer; 2010 Nov; 20(8):1341-3. PubMed ID: 21051974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation of FOXL2 in granulosa-cell tumors of the ovary.
    Shah SP; Köbel M; Senz J; Morin RD; Clarke BA; Wiegand KC; Leung G; Zayed A; Mehl E; Kalloger SE; Sun M; Giuliany R; Yorida E; Jones S; Varhol R; Swenerton KD; Miller D; Clement PB; Crane C; Madore J; Provencher D; Leung P; DeFazio A; Khattra J; Turashvili G; Zhao Y; Zeng T; Glover JN; Vanderhyden B; Zhao C; Parkinson CA; Jimenez-Linan M; Bowtell DD; Mes-Masson AM; Brenton JD; Aparicio SA; Boyd N; Hirst M; Gilks CB; Marra M; Huntsman DG
    N Engl J Med; 2009 Jun; 360(26):2719-29. PubMed ID: 19516027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis (c.402C>G) of the FOXL2 gene and immunohistochemical expression of the FOXL2 protein in testicular adult type granulosa cell tumors and incompletely differentiated sex cord stromal tumors.
    Hes O; Vaněček T; Petersson F; Grossmann P; Hora M; Perez Montiel DM; Steiner P; Dvořák M; Michal M
    Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):347-51. PubMed ID: 21293260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aromatase is a direct target of FOXL2: C134W in granulosa cell tumors via a single highly conserved binding site in the ovarian specific promoter.
    Fleming NI; Knower KC; Lazarus KA; Fuller PJ; Simpson ER; Clyne CD
    PLoS One; 2010 Dec; 5(12):e14389. PubMed ID: 21188138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXO1 mitigates the SMAD3/FOXL2
    Secchi C; Benaglio P; Mulas F; Belli M; Stupack D; Shimasaki S
    J Transl Med; 2021 Feb; 19(1):90. PubMed ID: 33639972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The FOXL2 C134W mutation is characteristic of adult granulosa cell tumors of the ovary.
    Jamieson S; Butzow R; Andersson N; Alexiadis M; Unkila-Kallio L; Heikinheimo M; Fuller PJ; Anttonen M
    Mod Pathol; 2010 Nov; 23(11):1477-85. PubMed ID: 20693978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The transcriptional targets of mutant FOXL2 in granulosa cell tumours.
    Rosario R; Araki H; Print CG; Shelling AN
    PLoS One; 2012; 7(9):e46270. PubMed ID: 23029457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Oncogenic FOXL2 C134W Mutation Is a Key Driver of Granulosa Cell Tumors.
    Llano E; Todeschini AL; Felipe-Medina N; Corte-Torres MD; Condezo YB; Sanchez-Martin M; López-Tamargo S; Astudillo A; Puente XS; Pendas AM; Veitia RA
    Cancer Res; 2023 Jan; 83(2):239-250. PubMed ID: 36409821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and Validation of Differential Phosphorylation Sites of the Nuclear FOXL2 Protein as Potential Novel Biomarkers for Adult-Type Granulosa Cell Tumors.
    Suh DS; Oh HK; Kim JH; Park S; Shin E; Lee K; Kim YH; Bae J
    J Proteome Res; 2015 Jun; 14(6):2446-56. PubMed ID: 25871347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential apoptotic activities of wild-type FOXL2 and the adult-type granulosa cell tumor-associated mutant FOXL2 (C134W).
    Kim JH; Yoon S; Park M; Park HO; Ko JJ; Lee K; Bae J
    Oncogene; 2011 Apr; 30(14):1653-63. PubMed ID: 21119601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uterine Tumor Resembling Ovarian Sex Cord Tumor (UTROSCT) Commonly Exhibits Positivity With Sex Cord Markers FOXL2 and SF-1 but Lacks FOXL2 and DICER1 Mutations.
    Croce S; de Kock L; Boshari T; Hostein I; Velasco V; Foulkes WD; McCluggage WG
    Int J Gynecol Pathol; 2016 Jul; 35(4):301-8. PubMed ID: 26598979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathogenesis in granulosa cell tumor is not only due to somatic FOXL2 mutation.
    Wang WC; Lai YC
    J Ovarian Res; 2014 Sep; 7():88. PubMed ID: 25297715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXL2 Mutation Status in Sex Cord-stromal Tumors Cannot be Predicted by Morphology.
    Wessman S; Fuentes BB; Severin-Karlsson J; Westbom-Fremer S; Nistér M; Kokaraki G; Petta TB; Haglund F; Carlson JW
    Int J Gynecol Pathol; 2024 Jan; 43(1):78-89. PubMed ID: 37255476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXL2 molecular testing in ovarian neoplasms: diagnostic approach and procedural guidelines.
    Kommoss S; Anglesio MS; Mackenzie R; Yang W; Senz J; Ho J; Bell L; Lee S; Lorette J; Huntsman DG; Blake Gilks C
    Mod Pathol; 2013 Jun; 26(6):860-7. PubMed ID: 23348906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and genetic analysis of recurrent adult-type granulosa cell tumor of the ovary: Persistent preservation of heterozygous c.402C>G FOXL2 mutation.
    Yanagida S; Anglesio MS; Nazeran TM; Lum A; Inoue M; Iida Y; Takano H; Nikaido T; Okamoto A; Huntsman DG
    PLoS One; 2017; 12(6):e0178989. PubMed ID: 28594898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.